ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2026
CSPG4 Mediates Inflammatory, Cell Death, and Senescence Responses in Enteric Glia Exposed to Clostridioides difficile Toxins.
Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Clostridioides difficile infection (CDI) is a persistent public health problem worldwide. C. difficile toxins A (TcdA) and B (TcdB) can affect enteric glial cells, an important component of the enteric nervous system. Here, we aimed to identify the profile of C. difficile toxin receptors expressed by enteric glia and investigate the contribution of the chondroitin sulfate proteoglycan receptors (CSPG4) in mediating inflammatory response, cell death, and senescence in enteric glia exposed to TcdA or TcdB. We found that human, mouse, and rat enteric glia express all of the previously recognized C. difficile toxin receptors. However, in vitro, C. difficile toxins significantly increased CSPG4 expression in enteric glia. In vivo, CDI also increased CSPG4 expression in colonic and cecal tissues. Blockage of CSPG4 significantly decreased IL-6 and S100B gene expression, as well as reduced the nuclear translocation of NFκB and STAT3 in enteric glia exposed to TcdB, but not TcdA. Interestingly, blockade of CSPG4 also decreased senescence-associated beta-galactosidase (SA-β-galactosidase) activity and other senescence markers (γH2AX, p16 and p21) in enteric glia exposed to TcdA or TcdB. However, CSPG4 blockade reduced cell death promoted by TcdA, but not TcdB. Taken together, these findings show that enteric glia, by expressing all known C. difficile toxin receptors, can respond directly to TcdA or TcdB. However, CSPG4 seems to play an important role in cell death and inflammatory response promoted by TcdA and TcdB, respectively, as well as senescence induced by both toxins.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.